The event was organized by the Society for Immunotherapy of Cancer (SITC), with Frank’s long-term collaborator Professor Daniel Powell serving as one of the core organizers. Professor Powell’s research laboratory has long led pioneering research in engineered T-cell therapeutics.
Highlighted agenda of the conference covered cutting-edge progress across in vivo cell therapy, next-generation TIL development and novel T cell engager combination strategies, including featured academic sharing from Dr. Stephanie Goff of the U.S. National Cancer Institute (NCI).
Hosting this high-standard top-tier cell therapy conference in Tucson marks the rising industry influence of Tucson within the global cell and gene therapy industrial landscape. Our team looks forward to ongoing academic exchanges and industrial cooperation stemming from the conference’s innovative research findings.